About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Houston | 155 Studies

Clinical Trials Alzheimer's DiseaseHouston

Alzheimer's Disease Clinical Trials in Houston

Find 155 clinical trials for alzheimer's disease near Houston, Texas. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 155 trials

CompletedLong-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's DiseaseTo evaluate the long-term safety and tolerability of idalopirdine (Lu AE58054) as adjunctive therapy to donepezil in patients with mild-moderate Alzheimer's Disease (AD).NCT02079246·Birmingham, Alabama and 257 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedStudy of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseThe purpose of this study is to evaluate the safety and efficacy of 2 fixed doses of EVP-6124 compared to placebo for 26 weeks in subjects with mild to moderate Alzheimer's…NCT01969136·Tucson, Arizona and 80 others

CompletedStudy Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET StudyThis study seeks to confirm a demonstrated treatment effect of intepirdine (RVT-101) as an adjunctive therapy to donepezil for the treatment of subjects with Alzheimer's disease.NCT02585934·Phoenix, Arizona and 196 others

CompletedEARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)12-week, open-label study to evaluate the effectiveness and safety of donepezil hydrochloride in Hispanic patients with mild to moderate Alzheimer's Disease (AD) in the U.S.NCT00230568·Phoenix, Arizona and 34 others

CompletedEfficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's DiseaseThe objectives of the study are to evaluate the safety, tolerability and efficacy of AVP-923 compared to placebo, for the treatment of symptoms of agitation in participants with…NCT01584440·Phoenix, Arizona and 43 others

CompletedAssessing Clinical Outcomes in Alzheimer's Disease AgitationThis is a multi-center, double-blind, placebo-controlled, randomized withdrawal study to evaluate the efficacy and safety of AXS-05 compared to placebo in the treatment of…NCT04797715·Sun City, Arizona and 62 others

Active not recruitingGlutathione, Brain Metabolism and Inflammation in Alzheimer's DiseaseAlzheimer's disease (AD) is associated with significant, progressive cognitive decline.NCT04740580·Houston, Texas

CompletedA Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's DiseaseThis study seeks to evaluate the efficacy and safety of ABBV-8E12 in participants with early Alzheimer's disease (AD).NCT02880956·Phoenix, Arizona and 67 others

CompletedEstrogen Hormone ProtocolEstrogen is a hormone that is dominant in the female reproductive system. In women, most estrogen is produced by the ovaries.NCT00000177·Birmingham, Alabama and 24 others

CompletedBapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)This is a multicenter, double-blind, placebo controlled, randomized, outpatient, multiple dose study in male and female patients ages 50 to less than 89 years with mild to…NCT00575055·Birmingham, Alabama and 185 others

CompletedAn Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD SubjectsThis study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype.NCT04770220·Phoenix, Arizona and 94 others

CompletedIdalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With DonepezilTo establish efficacy of Idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD).NCT02006641·Phoenix, Arizona and 161 others

WithdrawnA Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's DiseaseHope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible…NCT04228666·Houston, Texas

CompletedTo Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.The purpose of this study is to find out if atovastatin, when taken with a cholinesterase inhibitor, is effective for treating Alzheimer's disease.NCT00151502·Sun City, Arizona and 98 others

CompletedStudy of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase InhibitorTo establish efficacy of idalopirdine as adjunctive therapy to acetylcholinesterase inhibitors (AChEIs) for symptomatic treatment of patients with mild-moderate Alzheimer's…NCT02006654·Mesa, Arizona and 106 others

RecruitingDevelopment of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD DementiaBio-Hermes-002 is a 120-day cross-sectional study that will result in a blood, CSF, retinal, digital, MRI, and PET brain imaging biomarker database that can be used to determine…NCT06584357·Atlantis, Florida and 25 others

CompletedStudy Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)The purpose of this study is determine the safety, tolerability, and efficacy of 3 doses of lecozotan SR in patients with mild to moderate Alzheimer's Disease over 12 weeks.NCT00151398·Phoenix, Arizona and 55 others

CompletedVITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)The purpose of this study is to determine whether reduction of homocysteine levels with high-dose folate (folic acid), B6, and B12 supplementation will slow the rate of cognitive…NCT00056225·Birmingham, Alabama and 37 others

TerminatedA Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseThe purpose of this study was to test whether two investigational drugs called CAD106 and CNP520, administered separately, could slow down the onset and progression of clinical…NCT02565511·Phoenix, Arizona and 128 others

CompletedAn Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's TypeObjectives: The objective of this study will be to determine the safety, tolerability, drug blood levels, and efficacy of each of three doses of NS 2330 (Tesofensine) given once…NCT00153010·Mesa, Arizona and 86 others

PreviousPage 6 of 8Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia